COVID Research Trials
CO-Sprout Pilot Clinical Study
Do you have COVID-19 and are between 20+0 to 36+0 weeks pregnant?
Monash Health and Monash University are currently recruiting patients to participate in the CO-Sprout Pilot Clinical Study here at Monash Health and Jessie McPherson Private Hospital. CO-Sprout is studying whether a naturally occurring broccoli sprout supplement can be used in pregnant patients with COVID-19 to help reduce the duration of symptoms and improve pregnancy outcomes. Currently this study is underway through Monash Health (Monash Medical Centre Clayton, Dandenong Hospital or Casey Hospital) and Jessie McPherson Private Hospital. In order to participate, you must be booked for your pregnancy care at one of these hospitals.
The study involves 14 days of either broccoli sprout capsules or placebo (sugar pill) taken twice a day and will involve two home visits where a medical research staff member will attend to you at home. During this home visit, we will collect blood, urine and PCR nasal swab samples. You can also elect to optionally provide a stool sample so that we can investigate the effects on the gut and or placenta and umbilical cord samples at the time of birth.
In order to be eligible, you must be:
- Between 20+0 to 36+0 weeks pregnant with a singleton baby (i.e. not twins/triplets)
- Positive PCR or RAT test within last 5 days
- First COVID-19 symptom within last 7 days
- ≥18 years of age
- Not already taking broccoli sprout supplements
- Not currently using anti-viral, antibiotic or monoclonal antibody therapy
From all of the study team at CO-Sprout, we hope you start feeling better soon.
If you are interested in participating or learning more about the study, please contact the study team on either:
Study Mobile Phone: 0458 439 896
To learn more about the study, watch the video below.